References
Yang B. Z., Li Z. L., Cui Z. Y., and Luo Y. M. (1991)Int. J. Immunopharmacol. 13, 825–829.
Goust J. M., Chenais F., Carnes J. E., Hanes C. G., Fudenberg H. H., and Hogan E. L. (1978)Neurology 28, 421; and unpublished observations.
Baoqun L., Jianyang X., and Chengguanliang (1990) inRecent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Maruzen, Tokyo, Japan, 339.
Pekarek J., Cech K., Nevsimal O., Barnet K., Doutlik S., and Cervenkova O. (1990) inRecent Advances in Transfer Factor and Dialyzable Leucocyte Extract. Maruzen, Tokyo, Japan, 326.
Salier J. P., Goust J. M., Link H., Pandey J. P., Daveau M., and Fudenberg H. H. (1983)J. Immunogenet. 10, 311.
Fudenberg H. H., Coleman M., Rosenberger D., and Fudenberg H. L. (1989)Clin. Res. 37, 556a (Abstract).
Singh V. J. and Fudenberg H. H. (1988)Ann. NY Acad. Sci. 504, 602.
Fudenberg H. H. (1992) inThe Clinical and Scientific Basis of Myalgic Enkephalitis Chronic Fatigue, Hyde B., ed., Ottawa U. Press, Ottawa, Canada, and Ogdenburg, NY, pp. 644–653.
Visa D., Pizza G., and Fudenberg H. H. (1994) in preparation.
Fudenberg H. H., Whitten H. D., Arnaud P., and Khansari N. (1984).Clin. Immunol. Imunopathol. 32, 127–131.
Fudenberg H. H., Whitten H. D., Chou Y. K., Arnaud P., Shums A. A., and Khansari N. K. (1984)Biomedicine and Pharmacotherapy 38, 285–290.
Kilidreas K., Latov L., Strauss D., Gorig A., Hashim G., Gorman J., and Sadiq S. (1992)Lancet ii, 571–572.
Fudenberg H. H. and Pizza G. (1993) inProgress in Drug Research. Birkhuser, Basel, Switzerland.
Fudenberg H. H., Whitten H. D., Arnaud P., Khansari N., Tsand K. Y., and Hames C. G. (1984)Biomed. Pharmacol. 38, 290–297.
Fudenberg H. H. and Singh V. (1988)Drug Dev. Res. 15, 165–174.
Torack R. M. (1986)Neurosci. Lett. 71, 365–369.
McRae-Degueurce A., Booj S., Haglid K., Rosengren L., Karlsson J. E., and Karlsson I. (1987)Proc. Natl. Acad. Sci. USA 84, 9214–9218.
Miller C. A., Rudnicka M., Hinton D. R., Blanks J. C., and Kozlowski M. (1987)Proc. Natl. Acad. Sci. USA 84(23), 8657–8661.
Reisberg B. and Ferris S. H. (1988)Psychopharm. Bull. 24(4), 629–636.
Dirienzo W., Steffanini G. F., Miribel L., Paulling E. E., Canonica G. W., and Fudenberg H. H. (1986)Cell. Immunol. 103, 65–72.
Nel A. E., Dirienzo W., Stefanini G. F., Wooten M. W., Canonica G. W., Latanze G. R., Stevenson H. C., Miller P., Fudenberg H. H., and Galbraith R. M. (1986)Cell. Immunol. 103, 65–72.
Singh V. K. and Fudenberg H. H. (1987)Clin. Immunol. Newslett. 8, 165–166.
Galbraith G. M. P. and Fudenberg H. H. (1984)Clin. Immunol. Immunopathol. 31, 254–260.
Goust J. M. and Fudenberg H. H. (1983)J. Immunol. Meth. 59, 29–38.
Fudenberg H. H. (1982), unpublished observations.
Fudenberg H. H. (submitted) Influence of per cent granulocytes and degree of donor-patient contact or clinical efficacy of transfer factor.
Fudenberg H. H. (1994) Florence Nightingale Disease (FND): A multisystem experiment of nature. Observations and speculations on etiology and pathogenesis, in press.
Fudenberg H. H. (1990) First International Symposium on Chronic Fatigue Syndrome, Los Angeles, CA.
Deleted in proof.
Fudenberg H. H. (1984)In vitro test for evaluation of possible therapeutic agents in Alzheimer's Disease. US Patent Office.
Gadjusek D. C. (1993) Plenary Lecture at Univ. Göteborg Int. Symposium on Neurodegenerative Diseases, Jamaica.
Galbraith G. M. P., Emerson D., Fudenburg H. H., Gibbs C. J., and Gadjusek D. C. (1986)J. Clin. Invest. 78, 865–869.
Singh V. J. and Fudenberg H. H. (1989)Autoimmunity 3, 945–1001.
Singh V. K., Fudenberg H. H., Emerson D., and Coleman M. (1988)Ann. NY Acad. Sci. 540, 602–604.
Fudenberg H. H. and Singh V. K. (1988) inImmunological Aspects of Alzheimer's Disease and Brain Amyloidosis. IPSEN Foundation, Paris, publ.
Fudenberg H. H. and Singh V. J. (1988)Progress in Drug Research,32, 21–42.
Lundgren D. W. and Fales H. M. (1980)J. Biol. Chem. 217, 2163;255, 4481–4486.
Lawson A. M. and Chalmers R. A. (1980)Adv. Mass Spect. 8B, 1306–1313.
Leszek J. and Kowal-Gierczak B. (1989)Psychiatr. Pol. 23 (5–6), 373–378.
Leszek J. (1992) personal communication.
Leszek J., Inglot A. D., Cantell K., and Wasik A. (1991)Eur. J. Immunol. 555–563.
Fudenberg H. H. and Gadjusek D. C. (1980) unpublished observations.
Hasse A. T., et al. (1986)Can. J. Neurol. 13 (Suppl. 4), 449–450.
Gadjusek, D. C. (1984) personal communication.
Guiroy D. C. (1987)Proc. Natl. Acad. Sci. 7, 2073.
Khansari N., Whitten H. D., Chou Y. K., and Fudenberg H. H. (1985)J. Neuroimmunol. 7, 279–285.
Laing P., Knight J. G., Hill J. M., Harris A. G., Oxford J. S., Webster R. G., Markwell M. A. K., Paul S. M., and Peri C. B. (1989)Proc. Natl. Acad. Sci. USA 86, 1998–2002.
Oldstone M. (1993)Am. J. Path. in press.
Chapman J., Alroy G., Weiss Z., Faigon M., Feldon J., and Michaelson D. (1991)Neuroscience 40, 297–305.
Bradford H. F., Foley P., Docherty M., Fillit H., Luine V. N., McEwen B., et al. (1988)Can. J. Neurol. Sci. 16, 528–534.
Singh V. K. and Fudenberg H. H. (1987) inAlzheimer's Disease: Advances in Basic Research and Therapies. Wurtman R. J., Corkin S. H., and Growdon J. H., eds., pp. 597–602. Proceedings of the fourth Meeting of the International Study Group on the Pharmacology of Memory Disorder Associated with Aging. Zurich, Switzerland.
Marx J. (1992)Science 258, 550.
Beyreuther K. (1993) in discussion at Göteborg Symposium on Neurodegenerative Disorders.
Emerling M. (1993) in discussion at Göteborg Symposium on Neurodegenerative Disorders.
Wisniewki H. (1993) personal communication at Göteborg Symposium on Neurodegenerative Disorders.
Khansari N. and Fudenberg H. H. (1984)Scand. J. Immunol. 19, 337–342.
Chou Y. K., Stanley W., Virella G., Kilpatrick J. M., and Fudenberg H. H. (1987)Immunobiol. 174(4–5), 444–459.
Singh V. K. and Fudenberg H. H. (1986)J. Clin. Psychiat. 47, 592–595.
Whitehouse P. J., et al. (1987)Neurology 3, 905–909.
Roberts G. W., Nash M., Ince P. G., Royston M. C., and Gentleman S. M. (1993)Neuroreport 4, 7.
Fudenberg H. H. and Pitts F. (1985) unpublished observations.
Author information
Authors and Affiliations
Additional information
Published in part in Fudenberg H. H. (1990)Clin. Res. 38, 595A; and Fudenberg H. H. (1992)Clin. Res. 40, 440A.
Rights and permissions
About this article
Cite this article
Fudenberg, H.H. Heterogeneity of Alzheimer's disease. Mol Neurobiol 9, 55–71 (1994). https://doi.org/10.1007/BF02816105
Issue Date:
DOI: https://doi.org/10.1007/BF02816105